Oxytocin, Couple Interaction and Wound Healing
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01594775|
Recruitment Status : Completed
First Posted : May 9, 2012
Last Update Posted : February 25, 2014
effects of intranasal oxytocin and couple interaction on wound healing.
- Trial with medicinal product
|Condition or disease||Intervention/treatment||Phase|
|Healthy Volunteers||Drug: Syntocinon (Oxytocin) nasal spray Drug: Placebo||Phase 1|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||160 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Participant, Investigator)|
|Study Start Date :||October 2011|
|Actual Primary Completion Date :||October 2013|
|Actual Study Completion Date :||October 2013|
|Active Comparator: nasal spray||
Drug: Syntocinon (Oxytocin) nasal spray
two-times daily self-administration of nasal spray containing active substance (oxytocin) during five days after wounding.
|Placebo Comparator: Placebo||
two-times daily self-administration of nasal spray containing placebo during five days after wounding.
- wound size [ Time Frame: seven days ]wound healing process within seven days after wounding
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01594775
|University Hospital Zurich, Dept. of Dermatology|
|Zurich, Switzerland, 8091|
|Study Director:||01 Studienregister MasterAdmins||UniversitaetsSpital Zuerich|
|Principal Investigator:||Severin Laeuchli, MD||University Hospital Zurich, Division of Dermatology|